Final-Program-ATS-2023-AP.vp

54

SUNDAY • MAY 21

1022 HIV and Tuberculosis Are Associated With Lower Diffusing Capacity for Carbon Monoxide in Ugandan Adults/ K.L. Byanova, San Francisco, CA 1023 Prior Tuberculosis and Female Sex Are Major Risk Factors for Chronic Hypoxemia in Kenyan Adults/ N. Navuluri, Durham, NC 1024 A Systematic Review of National Institutes of Health Funding for Tuberculosis Comorbidities/ M. Carwile, Boston, MA 1025 Xpert MTB/RIF Test as the Initial Diagnostic Test in the Diagnosis of Pulmonary Tuberculosis: A Pragmatic Trial/ Y.-W. Huang, Changhua, Taiwan

1006 Impact of COVID-19 on Multi-drug Resistant Tuberculosis (MDR-TB) Registrations and Outcomes in Pakistan: The Challenging Journey Continues/ M.D. Imran, Peshawar, Pakistan 1007 Unmasking Pulmonary Tuberculosis in Patients Undergoing Chest Radiography During COVID 19 Pandemic in a Tertiary Care Center in India/ D. Shastri, Johnson City, TN 1008 Factors Associated With Delays at Tuberculosis Treatment Centres in South-West Nigeria: A Cross-sectional Study/ O. Olayanju, Cape Town, South Africa 1009 Approaches to Addressing Positive Tuberculosis Screening in Patients Receiving Biologic Medications: An Upstate New York Cohort Analysis/ M. Connolly, Rochester, NY 1010 Epidemiology and Risk Factors Associated With Osteoarticular Tuberculosis/ A. Ashkin, Naples, FL 1011 Extrapulmonary Tuberculosis in Florida From 2012-2021/ A. Ashkin, Naples, FL 1012 Pseudotumour Presentation of Pulmonary Tuberculosis/ Z. Laklaai, Casablanca, Morocco 1013 Retrospective Review of Management of Smear-negative Pulmonary Mycobacterium Tuberculosis/ M. Oudah, Washington, DC 1014 Mucous Gland Abnormalities in Latent and Active Tuberculosis: A Histological Demonstration/ A.M. Hutton, Birmingham, AL 1015 An Exhaled microRNA Panel Interrogated for Sarcoidosis and Mediastinal Tuberculosis: A Pilot Study in a TB-endemic Setting/ B.R. Pattnaik, New Delhi, India 1016 The Error Rate of Phenotypic Drug Susceptibility Tests According to Specimens in Patients With Tuberculosis/ Y. NA, Gwangju, Korea, Republic of 1017 Baseline and Treatment Emergent Bedaquiline Resistance in Drug-resistant Tuberculosis: A Systematic Review and Meta-analysis/ R. Perumal, Durban, South Africa 1018 Treatment Outcomes of Multidrug-resistant Tuberculosis With Selective Use of New Drugs Guided by an Expert Committee/ Y.S. Kwon, Gwangju, Korea, Republic of 1019 Small Airway Involvement After Tuberculosis Treatment: Findings From a Post-tuberculosis Cohort Study in Georgia/ W. Du, Atlanta, GA 1020 Increased Lung Cancer Risk in Tuberculosis Survivors and Its Associated Risk Factors: A Korean Population-based Study/ H. Choi, Seoul, Korea, Republic of 1021 Lung Function Abnormalities Are Common After Microbiologic Cure of Drug Sensitive Tuberculosis in Southwest Uganda/ E. Nuwagira, Mbarara, Uganda

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

A28

WHAT IS TRENDY IN THE PNEUMONIA WORLD?

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 201 (Level 2)

Poster Viewing

9:00-9:45 9:45-11:00

Discussion

Chairing: B.E. Jones, MD, MSc, Salt Lake City, UT F. Sanz, MD, Valencia Spain 601 The Impact of Pseudomonas Aeruginosa Isolation on Exacerbations, Hospitalizations and All-cause Mortality in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Case-control Study/ E. Faniadou, London, United Kingdom 602 Diagnosis and Treatment of Patients With Suspected Pneumonia in 28 Utah Urgent Care Clinics/ N.C. Dean, Murray, UT 603 Association Between Bacteria Isolated From Admission Bronchoalveolar Lavage and Hospital Mortality in Inhalation Injury/ T.D. Coston, Seattle, WA 604 Inhalation Injury Grade and Risk of Ventilator-associated Pneumonia/ T.D. Coston, Seattle, WA 605 Integrative Microbial Cell-free DNA Sequencing and Host-response Profiling in the Lower Respiratory Tract and Systemic Circulation of Patients With Severe Pneumonia/ M.K. Hensley, Pittsburgh, PA 606 Comparing the Accuracy of Mini-BAL to Bronchoscopic BAL in the Diagnosis of Pneumonia Among Ventilated Patients: A Systematic Literature Review/ J. Tepper, Indianapolis, IN

ATS 2023 • Washington, DC